| abstract |
The present invention provides a method for enhancing expression of the SCN1A gene, an RNA or RNA expression vector for enhancing the expression of the SCN1A gene used in the method, a cell having enhanced expression of the SCN1A gene, and a cell preparation containing the cell. A method for enhancing the expression of an SCN1A gene using gRNA or crRNA targeting at least one Cas9 endonuclease binding site present on the promoter region of the SCN1A gene, an RNA expression vector used in the method, A cell having enhanced expression of the SCN1A gene and a cell preparation containing the cell. [Selection figure] None |